Advertisement · 728 × 90
#
Hashtag
#AI_Drug_Discovery
Advertisement · 728 × 90
Preview
Hitachi Develops Confidential AI Drug Discovery Platform to Accelerate Open Innovation Hitachi is set to launch a confidential AI platform to enhance drug discovery, collaborating with MOLCURE to ensure safety and efficiency without data exposure.

Hitachi Develops Confidential AI Drug Discovery Platform to Accelerate Open Innovation #Japan #Tokyo #AI_Drug_Discovery #Hitachi #MOLCURE

0 0 0 0
Preview
Viva Biotech Showcases Strong 2025 Results: AI Drug Discovery and CDMO Growth Uncovered Viva Biotech Reports impressive 2025 results showcasing growth in AI-driven drug discovery and rapid scaling of CDMO projects, reinforcing leadership.

Viva Biotech Showcases Strong 2025 Results: AI Drug Discovery and CDMO Growth Uncovered #China #Shanghai #Viva_Biotech #AI_Drug_Discovery #CDMO_Projects

0 0 0 0
Preview
Innovative Global R&D Collaboration Between Insilico Medicine and Eli Lilly to Advance Drug Discovery Insilico Medicine and Eli Lilly have entered a groundbreaking collaboration leveraging artificial intelligence for drug discovery in various therapeutic areas.

Innovative Global R&D Collaboration Between Insilico Medicine and Eli Lilly to Advance Drug Discovery #USA #Cambridge #Insilico_Medicine #AI_Drug_Discovery #Lilly

0 0 0 0
Preview
Insilico Medicine's PandaClaw Revolutionizes Therapeutic Discovery with AI Technologies Insilico Medicine introduces PandaClaw, an advanced AI tool that simplifies therapeutic discovery for biologists by automating complex analyses and offering real-time insights.

Insilico Medicine's PandaClaw Revolutionizes Therapeutic Discovery with AI Technologies #United_States #Cambridge #Insilico_Medicine #AI_Drug_Discovery #PandaClaw

0 0 0 0
Preview
Accelerating Drug Discovery: The Innovative Collaborations Between Insilico Medicine and CMS Insilico Medicine partners with CMS to leverage AI-driven drug discovery for central nervous system and autoimmune diseases, enhancing treatment options.

Accelerating Drug Discovery: The Innovative Collaborations Between Insilico Medicine and CMS #China #Cambridge #Insilico_Medicine #CMS #AI_Drug_Discovery

0 0 0 0
Preview
Lunai Bioworks Unveils Exciting AI Innovations and Future Prospects Lunai Bioworks has successfully launched its AI platform, promising revolutionary advancements in drug discovery and biotechnology, with exciting partnerships ahead.

Lunai Bioworks Unveils Exciting AI Innovations and Future Prospects #United_States #biotechnology #Sacramento #AI_Drug_Discovery #Lunai_Bioworks

0 0 0 0
Preview
Deep EigenMatics Achieves Unprecedented Success in AI Drug Discovery, Outperforming Big Pharma Deep EigenMatics has secured the top spot in AI-driven drug discovery, surpassing major pharmaceutical companies in patent output for 2025. Discover their innovative methods.

Deep EigenMatics Achieves Unprecedented Success in AI Drug Discovery, Outperforming Big Pharma #United_States #Houston #AI_Drug_Discovery #Drug_Design #Deep_EigenMatics

0 0 0 0
Preview
Pioneering the Future of Drug Discovery: Insights from XtalPi’s International Symposium XtalPi recently held its 2026 International Symposium, showcasing innovative AI techniques in molecular glue drug discovery, featuring expert insights worldwide.

Pioneering the Future of Drug Discovery: Insights from XtalPi’s International Symposium #China #Shanghai #AI_Drug_Discovery #XtalPi #molecular_glue

1 0 0 0
Preview
Lunai Bioworks Launches New AI-Driven Drug Discovery for Alcohol Use Disorder Treatments Lunai Bioworks has achieved a major milestone in its NIH-funded initiative, embarking on a new AI program aimed at discovering treatments for Alcohol Use Disorder affecting millions in the U.S.

Lunai Bioworks Launches New AI-Driven Drug Discovery for Alcohol Use Disorder Treatments #USA #Sacramento #AI_Drug_Discovery #AUD #Lunai_Bioworks

0 0 0 0
Preview
Abcam Partners with IHI to Transform AI-Driven Drug Discovery Abcam has announced its collaboration in the Innovative Health Initiative Project LIGAND-AI, aimed at enhancing AI-driven drug discovery through open science and extensive data sharing.

Abcam Partners with IHI to Transform AI-Driven Drug Discovery #Cambridge #United_Kingdom #AI_Drug_Discovery #LIGAND-AI #Abcam

0 0 0 0
Preview
Illumina Launches the Billion Cell Atlas for Enhanced AI-Driven Drug Discovery Illumina has unveiled the Billion Cell Atlas, a groundbreaking dataset designed to revolutionize drug discovery through AI, promising unprecedented insights into human diseases.

Illumina Launches the Billion Cell Atlas for Enhanced AI-Driven Drug Discovery #USA #San_Diego #Genomics #Illumina #AI_Drug_Discovery

0 0 0 0
Preview
CytoReason and Sanofi Strengthen Partnership to Enhance AI in Drug Discovery CytoReason has enhanced its collaboration with Sanofi to harness AI for drug discovery, aiming to improve R&D processes and patient insights.

CytoReason and Sanofi Strengthen Partnership to Enhance AI in Drug Discovery #Israel #Tel_Aviv #AI_Drug_Discovery #Sanofi #CytoReason

0 0 0 0
Preview
Pierre Fabre and Iktos Join Forces for AI-Driven Oncology Drug Discovery Pierre Fabre Laboratories collaborates with Iktos to accelerate drug discovery in oncology using AI, showcasing their commitment to advancing cancer research.

Pierre Fabre and Iktos Join Forces for AI-Driven Oncology Drug Discovery #France #Pierre_Fabre #AI_Drug_Discovery #Iktos #Castres

0 0 0 0
Preview
Pierre Fabre and Iktos Join Forces to Revolutionize Cancer Drug Discovery with AI Pierre Fabre and Iktos announce a groundbreaking collaboration leveraging AI for drug discovery in oncology, enhancing treatment options for patients.

Pierre Fabre and Iktos Join Forces to Revolutionize Cancer Drug Discovery with AI #France #Pierre_Fabre #AI_Drug_Discovery #Iktos #Castres

0 0 0 0
Preview
Insilico Medicine Achieves Milestone IPO at Hong Kong Stock Exchange, Transforming Drug Discovery Landscape Insilico Medicine, backed by Qiming Venture Partners, makes a significant IPO debut on Hong Kong Stock Exchange, setting new benchmarks in biotech.

Insilico Medicine Achieves Milestone IPO at Hong Kong Stock Exchange, Transforming Drug Discovery Landscape #China #Shanghai #Insilico_Medicine #AI_Drug_Discovery #Qiming_Venture_Partners

1 0 0 0
Preview
Insilico Medicine's Successful Hong Kong Stock Exchange Listing Marks Milestone for AI-Driven Drug Discovery Insilico Medicine has made headlines with its successful IPO on the Hong Kong Stock Exchange, driving innovation in AI-based drug discovery and expanding its market presence.

Insilico Medicine's Successful Hong Kong Stock Exchange Listing Marks Milestone for AI-Driven Drug Discovery #China #Shanghai #Insilico_Medicine #AI_Drug_Discovery #Qiming_Venture_Partners

1 0 0 0
Preview
Insilico Medicine Launches Groundbreaking Biotech IPO on Hong Kong Stock Exchange in 2025 Insilico Medicine emerges as a leader in AI-driven drug discovery with a successful IPO on the Hong Kong Stock Exchange, raising HKD 2.277 billion.

Insilico Medicine Launches Groundbreaking Biotech IPO on Hong Kong Stock Exchange in 2025 #None #Hong_Kong #Insilico_Medicine #AI_Drug_Discovery #Hong_Kong_IPO

0 0 0 0
Preview
Insilico and Lilly Collaborate on Innovative AI-Driven Drug Discovery Partnership Insilico Medicine has partnered with Eli Lilly to enhance AI-driven drug discovery, combining expertise in innovative therapies that tackle unmet medical needs.

Insilico and Lilly Collaborate on Innovative AI-Driven Drug Discovery Partnership #United_States #Cambridge #Eli_Lilly #Insilico_Medicine #AI_Drug_Discovery

1 0 0 0
Preview
Compugen's Upcoming Participation in Stifel 2025 Healthcare Conference Highlights Industry Innovations Compugen Ltd. announces its participation at the Stifel 2025 Healthcare Conference, showcasing advancements in cancer immunotherapy and AI technologies.

Compugen's Upcoming Participation in Stifel 2025 Healthcare Conference Highlights Industry Innovations #New_York_City #Israel #cancer_therapy #Compugen #AI_Drug_Discovery

0 0 0 0
Preview
Revolutionizing Drug Discovery: Numerion Labs Unveils New AI Protocol for Rapid Screening Numerion Labs has published groundbreaking research on APEX, a protocol that allows rapid screening of billions of compounds, transforming drug discovery.

Revolutionizing Drug Discovery: Numerion Labs Unveils New AI Protocol for Rapid Screening #USA #San_Francisco #Apex #AI_Drug_Discovery #Numerion_Labs

0 0 0 0
Preview
Viva Biotech Achieves Prestigious APAC Technology Innovation Award for Drug Discovery Viva Biotech has been recognized with Frost & Sullivan's 2025 APAC Technology Innovation Leadership Award for its groundbreaking AI-driven drug discovery methods, showcasing significant advancements in the pharmaceutical R&D field.

Viva Biotech Achieves Prestigious APAC Technology Innovation Award for Drug Discovery #China #Shanghai #Frost_&_Sullivan #Viva_Biotech #AI_Drug_Discovery

0 0 0 0
Preview
Viva Biotech Honored with Frost & Sullivan's 2025 APAC Technology Innovation Leadership Award Viva Biotech's groundbreaking AI-driven drug discovery platform has earned it the 2025 APAC Technology Innovation Leadership recognition from Frost & Sullivan.

Viva Biotech Honored with Frost & Sullivan's 2025 APAC Technology Innovation Leadership Award #None #Frost_&_Sullivan #Viva_Biotech #AI_Drug_Discovery

0 0 0 0
Preview
Deep EigenMatics Awarded U.S. Patent for AI Advancements in Drug Discovery and Protein Design Deep EigenMatics, an AI drug discovery startup, has secured a U.S. patent for innovative methods in protein design and drug discovery, marking a significant breakthrough.

Deep EigenMatics Awarded U.S. Patent for AI Advancements in Drug Discovery and Protein Design #United_States #AI_Drug_Discovery #Sugar_Land #Protein_Design #Deep_EigenMatics

0 0 0 0
Preview
XtalPi and DoveTree Forge a $6 Billion Collaboration to Transform AI in Drug Discovery XtalPi and DoveTree embark on a groundbreaking collaboration valued at $6 billion to revolutionize drug discovery using AI and robotics, focusing on therapies for oncology, immunology, and more.

XtalPi and DoveTree Forge a $6 Billion Collaboration to Transform AI in Drug Discovery #USA #Cambridge #AI_Drug_Discovery #XtalPi #DoveTree

0 0 0 0
Preview
Understanding AI Drug Discovery: A Two-Hour Live Seminar by CMC Research on September 17th, 2025 Join the informative live seminar on AI drug discovery by CMC Research on September 17. Learn from Professor Hideyuki Shimizu during this insightful session.

Understanding AI Drug Discovery: A Two-Hour Live Seminar by CMC Research on September 17th, 2025 #Japan #Tokyo #AI_Drug_Discovery #CMC_Research #Hideyuki_Shimizu

0 0 0 0
Preview
Revolutionary AI-Powered Platform Accelerates Peptide Drug Discovery and Development Atombeat Inc. and BioDuro join forces to unveil an innovative AI-driven platform designed to streamline peptide drug discovery, promising faster and more efficient results.

Revolutionary AI-Powered Platform Accelerates Peptide Drug Discovery and Development #United_States #San_Diego #AI_Drug_Discovery #BioDuro #Atombeat_Inc.

0 0 0 0
Preview
XtalPi and Pfizer Forge Stronger Partnership in AI-Powered Drug Discovery XtalPi and Pfizer have expanded their collaboration to develop a next-gen molecular modeling platform, enhancing AI-driven drug discovery methods.

XtalPi and Pfizer Forge Stronger Partnership in AI-Powered Drug Discovery #USA #Cambridge #AI_Drug_Discovery #Pfizer #XtalPi

0 0 0 0
Preview
Isomorphic Labs Welcomes Dr. Ben Wolf as Chief Medical Officer to Drive AI in Drug Discovery In a significant move to enhance its drug discovery efforts, Isomorphic Labs has appointed Dr. Ben Wolf as Chief Medical Officer, establishing a strong US presence.

Isomorphic Labs Welcomes Dr. Ben Wolf as Chief Medical Officer to Drive AI in Drug Discovery #USA #Cambridge #AI_Drug_Discovery #Isomorphic_Labs #Ben_Wolf

0 0 0 0
Preview
Isomorphic Labs Welcomes Dr. Ben Wolf as Chief Medical Officer and Expands into the US Market Isomorphic Labs has appointed Dr. Ben Wolf as the Chief Medical Officer, marking its entry into the US market as a key hub for AI-driven drug discovery.

Isomorphic Labs Welcomes Dr. Ben Wolf as Chief Medical Officer and Expands into the US Market #USA #Cambridge,_Massachusetts #AI_Drug_Discovery #Isomorphic_Labs #Ben_Wolf

0 0 0 0
Preview
Insilico Medicine's Groundbreaking Publication on Rentosertib and AI-Driven Drug Development Insilico Medicine has made significant strides in drug development with Rentosertib for IPF, utilizing innovative AI techniques. Promising results were published.

Insilico Medicine's Groundbreaking Publication on Rentosertib and AI-Driven Drug Development #United_States #Cambridge #Insilico_Medicine #AI_Drug_Discovery #Rentosertib

0 0 0 0